subject: CHEBI:9667

subject_name: Triamcinolone

object_name: laryngeal disorder


subject: CHEBI:9667

object_name: Cough

tested_intervention: yes


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: colorectal cancer

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:6096882

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:6096882

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:6096882

object_name: peritoneal carcinomatosis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UMLS:C5670607

subject_name: Neem Mouthrinse

object_name: Oral Mucositis


subject: UMLS:C5670607

object_name: stomatitis


subject: UMLS:C5670607

object_name: oral mucositis


subject: CHEBI:3223

subject_name: Buspirone

object_name: Functional dysphagia


subject: CHEBI:3223

object_name: Ineffective esophageal peristalsis


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Headache


subject: CHEBI:6456

object_name: Headache, CTCAE


subject: UNII:V7FWP1D62O

subject_name: NERVE GROWTH FACTOR

object_name: traumatic encephalopathy


subject: UNII:V7FWP1D62O

object_name: traumatic brain injury


subject: GTOPDB:8268

subject_name: veltuzumab

object_name: follicular lymphoma


subject: UNII:BPD4DGQ314


subject: UMLS:C1529789


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Spasm of the cricopharyngeus muscle


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Sepsis


subject: CHEBI:89324

object_name: Sepsis, CTCAE


subject: CHEBI:89324

object_name: Injuries, Surgical


subject: CHEBI:89324

object_name: systemic inflammatory response syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: plasma cell myeloma


subject: UMLS:C0665297

subject_name: natalizumab


subject: UMLS:C2348115

subject_name: SN-38-Loaded Polymeric Micelles NK012

object_name: small cell lung carcinoma


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: interstitial lung disease 1


subject: CHEBI:16480

object_name: interstitial lung disease 2


subject: CHEBI:5931

subject_name: insulin human

object_name: Postoperative cognitive dysfunction


subject: CHEBI:5931

object_name: Emergence Delirium


subject: CHEBI:5931

object_name: post-operative delirium


subject: UMLS:C0123677

subject_name: NovoLog


subject: UMLS:C0123677


subject: UMLS:C0123677


subject: PUBCHEM.COMPOUND:2269

object_name: Posterior blepharitis


subject: PUBCHEM.COMPOUND:2269

object_name: dry eye syndrome


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: Oral Mucositis


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: stomatitis


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: oral mucositis


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: sign or symptom


subject: UMLS:C1655276

subject_name: T-KI

object_name: biliary tract cancer


subject: UMLS:C4085962

subject_name: Eramkafusp Alfa

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C4085962

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:5613

subject_name: Haloperidol

object_name: Huntington disease


subject: CHEBI:31687

subject_name: Idebenone


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:9123

subject_name: Sertraline


subject: UMLS:C0591615

subject_name: Hyalase

object_name: carpal tunnel syndrome 1


subject: UMLS:C0591615

object_name: carpal tunnel syndrome


subject: UMLS:C0591615

object_name: Chronic pain


subject: UNII:4I9I5X3Z6N

subject_name: VUDALIMAB

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C4725753

subject_name: Vudalimab


subject: UMLS:C1675748

object_name: Advanced cancer


subject: CHEBI:88249

subject_name: Mirdametinib


subject: UMLS:C3853885


subject: CHEMBL.COMPOUND:CHEMBL2108424

subject_name: MAGNESIUM GLYCINATE

object_name: Primary Insomnia


subject: UNII:IFN18A4Y6B

subject_name: Magnesium glycinate


subject: UMLS:C1701110

subject_name: Zactima

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: primary hyperparathyroidism


subject: PUBCHEM.COMPOUND:2735

object_name: hypercalcemia


subject: PUBCHEM.COMPOUND:2735

object_name: Hypercalcemia, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:6801

subject_name: Metformin

object_name: Increased circulating androgen concentration


subject: UMLS:C2584967

subject_name: Thrombopoietin receptor agonist

object_name: Primary immune thrombocytopenic purpura


subject: CHEBI:71954

subject_name: Buparlisib

object_name: colon carcinoma


subject: CHEBI:71954

object_name: colon cancer


subject: UMLS:C3537198

subject_name: Human Serum Albumin [EPC]

object_name: chronic hepatitis B virus infection


subject: UMLS:C3537198

object_name: hepatitis B


subject: UMLS:C0021734

subject_name: Roferon-A


subject: UMLS:C0021734


subject: CHEMBL.COMPOUND:CHEMBL2108508

subject_name: INTERFERON ALFA-2A


subject: CHEMBL.COMPOUND:CHEMBL2108508


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Aspirin-sensitive asthma with nasal polyps


subject: UMLS:C1550678

object_name: Aspirin exacerbated respiratory disease


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Alzheimer disease type 1


subject: CHEBI:4466

object_name: Alzheimer disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Rotator cuff tear


subject: CHEBI:150712

object_name: Partial tear of rotator cuff


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: UNII:C82R061MZ5

object_name: hypertension


subject: UNII:C82R061MZ5

object_name: Hypertension, CTCAE


subject: UNII:8JYO8VTR11


subject: UNII:8JYO8VTR11


subject: CHEBI:231352

subject_name: Resminostat

object_name: Advanced Colorectal Carcinoma


subject: UMLS:C2827533


subject: CHEBI:59594

subject_name: Colesevelam

object_name: Crohn disease


subject: UNII:QX8MJH6HGK

subject_name: TASIPIMIDINE

object_name: insomnia


subject: UNII:QX8MJH6HGK

object_name: Insomnia, CTCAE 3.0


subject: UNII:QX8MJH6HGK

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C4727755

subject_name: Tasipimidine


subject: UMLS:C4727755


subject: UMLS:C4727755


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: brain injury


subject: CHEBI:5931

subject_name: insulin human


subject: UMLS:C4287754

subject_name: Ragifilimab

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4287754

object_name: Embolism, Tumor


subject: UMLS:C4287754

object_name: Neoplasm Metastasis


subject: UMLS:C3641791

object_name: follicular lymphoma


subject: CHEBI:47426

subject_name: Furosemide

object_name: bronchopulmonary dysplasia


subject: CHEBI:47426

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:50659

subject_name: Dronedarone

object_name: Mucolipidosis 2


subject: CHEBI:50659

object_name: Disinhibition


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: lupus vulgaris


subject: PUBCHEM.COMPOUND:134506

object_name: lupus erythematosus


subject: PUBCHEM.COMPOUND:134506

object_name: discoid lupus erythematosus


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: UMLS:C0917987


subject: UMLS:C0917987


subject: UMLS:C0917987


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: colitis


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Colitis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: mucositis


subject: CHEBI:201674

subject_name: Icaritin

object_name: Solid Neoplasm


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Cancer of lung stage I


subject: UNII:28X28X9OKV

object_name: Lung squamous cell carcinoma stage I


subject: UNII:28X28X9OKV

object_name: Adenocarcinoma of lung, stage I


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Postsurgical menopause


subject: CHEBI:7936

object_name: Menopausal syndrome


subject: CHEBI:31431

object_name: cancer


subject: CHEBI:31431

object_name: neoplasm


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:4659


subject: CHEBI:8988

object_name: non-Hodgkin lymphoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:27953

subject_name: Physostigmine

object_name: Sepsis


subject: CHEBI:27953

object_name: Sepsis, CTCAE


subject: CHEBI:27953

object_name: septic shock


subject: UMLS:C5447480

subject_name: Interleukin-2/Interleukin-15 Receptor Agonist NL-201

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5447480

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447480

object_name: Adult Solid Neoplasm


subject: UMLS:C5447480


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:132922

object_name: Back pain


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: HIV infection


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C2350686

subject_name: Emselex

object_name: Urinary Urgency


subject: UMLS:C4724885

subject_name: Neo-multiple TAA-loaded Dendritic Cell Vaccine

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5400059

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5400059


subject: UMLS:C5400059

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5400059

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C5400059

object_name: lymphoma


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23

object_name: Inflammatory Response


subject: RXCUI:287523


subject: UMLS:C0378248

subject_name: Typhim VI


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: diffuse midline glioma, H3 K27M-mutant


subject: PUBCHEM.COMPOUND:70789204

object_name: diffuse intrinsic pontine glioma


subject: PUBCHEM.COMPOUND:70789204

object_name: diffuse glioma, H3 G34 mutant


subject: PUBCHEM.COMPOUND:70789204

object_name: Grade III Childhood Astrocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Adult Anaplastic Astrocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: anaplastic astrocytoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:70789204

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905

object_name: grade III glioma


subject: CHEBI:230905


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Surgical Complication


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:3T25U84H4U

subject_name: TELOTRISTAT ETIPRATE

object_name: Drug Interactions


subject: UMLS:C2825840

subject_name: Xermelo


subject: PUBCHEM.COMPOUND:9803433

object_name: Carcinoma breast stage IV


subject: UNII:9JD9B4S53T


subject: UNII:3S252O2Z4X

subject_name: Emapalumab

object_name: familial hemophagocytic lymphohistiocytosis type 1


subject: UNII:3S252O2Z4X


subject: UMLS:C4740903

subject_name: emapalumab-lzsg


subject: UMLS:C4740903


subject: CHEBI:174615

object_name: chronic graft versus host disease


subject: CHEBI:174615

object_name: Granulomatous disorder


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:52763

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Adult Solid Neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: DRUGBANK:DB10539

subject_name: Lettuce

object_name: Diet, Healthy


subject: CHEBI:8364

subject_name: Prazosin

object_name: alcohol withdrawal


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Delayed Graft Function


subject: PUBCHEM.COMPOUND:70789204


subject: DRUGBANK:DB05920

subject_name: RTA 744

object_name: glioma


subject: DRUGBANK:DB05920

object_name: malignant glioma


subject: UMLS:C4744981

subject_name: 5-FU Analog Prodrug NUC-3373

object_name: colorectal cancer


subject: UMLS:C4744981

object_name: colorectal carcinoma


subject: UMLS:C4744981

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4744981

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:9549299

subject_name: EGFR inhibitor


subject: PUBCHEM.COMPOUND:9549299


subject: UMLS:C5574906

subject_name: Epidermal growth factor receptor inhibitor


subject: UMLS:C5574906


subject: UMLS:C4287710

subject_name: Fluorescent Antibody SGM-101

object_name: Nodule of lung


subject: UMLS:C4287710

object_name: non-small cell lung carcinoma


subject: UMLS:C4287710

object_name: lung cancer


subject: UMLS:C4287710

object_name: lung neoplasm


subject: UMLS:C4287710

object_name: lung carcinoma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Hematoma, Subdural, Chronic


subject: DRUGBANK:DB10769

subject_name: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)

object_name: encephalitis


subject: UMLS:C0771080

subject_name: Japanese Encephalitis Vaccines


subject: UMLS:C3714691

subject_name: Japanese B encephalitis vaccine (product)


subject: CHEMBL.COMPOUND:CHEMBL3990003

subject_name: BALTALEUCEL-T

object_name: Lymphoma, Extranodal NK-T-Cell


subject: PUBCHEM.COMPOUND:11957447

subject_name: NOREPINEPHRINE BITARTRATE

object_name: Severe Sepsis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Wolman disease


subject: CHEBI:73604

object_name: lysosomal acid lipase deficiency


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: UNII:6A901E312A

object_name: Skin squamous cell carcinoma metastatic


subject: UNII:6A901E312A

object_name: Skin squamous cell carcinoma recurrent


subject: MESH:C000629782

subject_name: talimogene laherparepvec


subject: MESH:C000629782


subject: MESH:C000629782


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:LYJ1AEJ9YH

subject_name: CAMIDANLUMAB TESIRINE

object_name: Hodgkin Disease


subject: UNII:LYJ1AEJ9YH

object_name: Adult Hodgkin Lymphoma


subject: UNII:LYJ1AEJ9YH

object_name: Childhood Hodgkin Lymphoma


subject: UNII:LYJ1AEJ9YH

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:LYJ1AEJ9YH

object_name: non-Hodgkin lymphoma


subject: UNII:LYJ1AEJ9YH

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:LYJ1AEJ9YH

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C4053683

subject_name: ADC ADCT-301


subject: UMLS:C4053683


subject: UMLS:C4053683


subject: UMLS:C4053683


subject: UMLS:C4053683


subject: UMLS:C4053683


subject: UMLS:C4053683


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: marginal zone lymphoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: peritoneum cancer


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: UMLS:C2002939

object_name: B-cell lymphoma refractory


subject: UMLS:C2002939

object_name: diffuse large B-cell lymphoma


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:15698

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:15698

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:15698

object_name: soft tissue sarcoma


subject: UMLS:C3542918

subject_name: Docetaxel Lipid Microspheres

object_name: Advanced cancer


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Paediatric hypertension


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:57986

object_name: alcohol withdrawal


subject: CHEBI:57986

object_name: alcohol abuse


subject: CHEBI:57986

object_name: alcohol dependence


subject: CHEBI:57986

object_name: malnutrition


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Hydroxychloroquine adverse reaction


subject: PUBCHEM.COMPOUND:25199811

object_name: Recurrent Childhood Brain Neoplasm


subject: PUBCHEM.COMPOUND:25199811

object_name: childhood brain stem glioma


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: acromegaly


subject: UniProtKB:P19726

object_name: Acral overgrowth


subject: CHEBI:63612

subject_name: Nelarabine

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:63612

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:63612

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:63612

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:63612

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:63612

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:63612

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:63612

object_name: anaplastic large cell lymphoma


subject: CHEBI:63612

object_name: small intestine lymphoma


subject: CHEBI:63612

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:63612

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:63612

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:76018

subject_name: Riociguat

object_name: sleep apnea


subject: CHEBI:229221

subject_name: Fruquintinib


subject: CHEBI:229221

object_name: gastric adenocarcinoma


subject: CHEBI:229221

object_name: Childhood Gastric Carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox


subject: PUBCHEM.COMPOUND:135659064


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Unresectable Solid Neoplasm


subject: CHEBI:231598

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:231598

object_name: B-cell lymphoma stage IV


subject: CHEBI:231598

object_name: B-cell lymphoma stage III


subject: CHEBI:231598

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231598

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231598

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231598

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231598

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231598

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231598

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: CHEBI:65136

subject_name: Osbond acid

object_name: substance-related disorder


subject: CHEBI:34936

subject_name: propanil


subject: CHEBI:53488


subject: CHEBI:4640

subject_name: diphenylamine


subject: CHEBI:51676


subject: CHEBI:23757

subject_name: dihydrophaseic acid


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:28364

subject_name: Icosapent


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Myocardial injury


subject: CHEBI:167574


subject: CHEBI:8382

subject_name: Prednisone

object_name: Lymphoblastic T-cell lymphoma


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:52717

subject_name: Bortezomib


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: KEGG.COMPOUND:C02380


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:36373

subject_name: vindesine


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:15361

subject_name: pyruvate

object_name: Peripheral visual field defect


subject: MESH:D011773

subject_name: Pyruvates


subject: CHEBI:32816

subject_name: Pyruvic acid


subject: CHEBI:176839

subject_name: vitamin B3


subject: CHEBI:176839

object_name: open-angle glaucoma


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Clonal Cytopenia of Undetermined Significance


subject: CHEBI:22652

object_name: Refractory Lymphoma


subject: CHEBI:22652

object_name: Recurrent Lymphoma


subject: CHEBI:22652

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:22652

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:22652

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:22652

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:22652

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:22652

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:175901

object_name: chronic myelomonocytic leukemia


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:28748

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: head or neck cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Head and neck cancer metastatic


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Head and Neck Carcinoma


subject: PUBCHEM.COMPOUND:23724990

subject_name: Phytate Sodium

object_name: aortic stenosis


subject: PUBCHEM.COMPOUND:23724990

object_name: heart valve disorder


subject: CHEBI:187038

subject_name: PHYTATE


subject: CHEBI:187038


subject: UMLS:C0086808

subject_name: Phytate


subject: UMLS:C0086808


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Childhood Breast Carcinoma


subject: CHEBI:135530

object_name: breast carcinoma


subject: CHEBI:135530

object_name: breast cancer


subject: CHEBI:135530

object_name: Hot Flashes, CTCAE


subject: CHEBI:135530

object_name: Hot flashes


subject: CHEBI:42797

subject_name: Gabapentin

object_name: hepatobiliary disorder


subject: CHEBI:42797

object_name: liver disorder


subject: CHEBI:42797

object_name: cholestasis


subject: CHEBI:42797

object_name: Cirrhosis


subject: CHEBI:91991

subject_name: Talniflumate


subject: CHEBI:91991


subject: CHEBI:91991


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Oligometastasis


subject: CHEBI:31348

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IV Esophageal Adenocarcinoma AJCC v7


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UMLS:C5814342

subject_name: SerpinPC

object_name: Hereditary factor IX deficiency disease with inhibitor


subject: UMLS:C5814342

object_name: Hereditary factor VIII deficiency disease with inhibitor


subject: CHEBI:32660

subject_name: asparaginase

object_name: Leukemia Cutis


subject: CHEBI:32660

object_name: myeloid sarcoma


subject: CHEBI:32660

object_name: myeloid neoplasm


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C5854581

subject_name: Anti-CD39 Monoclonal Antibody AB598

object_name: Advanced cancer


subject: UMLS:C5854581

object_name: ovarian cancer


subject: UMLS:C5854581

object_name: ovarian neoplasm


subject: UMLS:C5854581

object_name: ovarian carcinoma


subject: UMLS:C5854581

object_name: bladder tumor


subject: UMLS:C5854581

object_name: urinary bladder carcinoma


subject: UMLS:C5854581

object_name: urinary bladder cancer


subject: UMLS:C5854581

object_name: childhood bladder carcinoma


subject: UMLS:C5854581

object_name: Stomach cancer


subject: UMLS:C5854581

object_name: gastric cancer


subject: UMLS:C5854581

object_name: cervical cancer


subject: UMLS:C5854581

object_name: cervical carcinoma


subject: UMLS:C5854581

object_name: carcinoma of esophagus


subject: UMLS:C5854581

object_name: esophageal cancer


subject: UMLS:C5854581

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5854581

object_name: neoplasm of esophagus


subject: UMLS:C5854581

object_name: non-small cell lung carcinoma


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: GTOPDB:12349

subject_name: zimberelimab

object_name: Advanced cancer


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UNII:16134B0YTH

object_name: ulcer disease


subject: UNII:16134B0YTH

object_name: ulcerative colitis


subject: UNII:16134B0YTH

object_name: inflammatory bowel disease 1


subject: UNII:16134B0YTH

object_name: Acute ulcerative colitis


subject: UNII:16134B0YTH

object_name: Ulcerative Colitis Flare


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Neuromuscular inhibition


subject: CHEBI:15407

object_name: Neuromuscular block, function


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:51230

object_name: vitiligo


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:167574

subject_name: Semaglutide

object_name: papilledema


subject: CHEBI:167574

object_name: Papilledema, CTCAE


subject: CHEBI:177637

object_name: pancreatic neoplasm


subject: CHEBI:177637

object_name: exocrine pancreatic carcinoma


subject: CHEBI:177637

object_name: malignant pancreatic neoplasm


subject: UMLS:C3661207

subject_name: Elpamotide


subject: UMLS:C3661207


subject: UMLS:C3661207


subject: UMLS:C2983782

object_name: colorectal cancer


subject: UMLS:C2983782

object_name: colorectal carcinoma


subject: UMLS:C2983782

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:91872

object_name: inflammatory breast carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:141969

subject_name: Tipifarnib


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: CHEBI:135926

subject_name: Udenafil

object_name: systolic heart failure


subject: UMLS:C2349009

subject_name: Zydena


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Miller-Dieker lissencephaly syndrome


subject: UNII:AQK7UBA1LS

object_name: myoclonic dystonia 11


subject: UNII:L24XJN68OW

object_name: lung cancer


subject: UNII:L24XJN68OW

object_name: lung neoplasm


subject: UNII:L24XJN68OW

object_name: lung carcinoma


subject: UMLS:C5960315

subject_name: EP4 Receptor Antagonist YY001

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: endometriosis


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Mastalgia


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine


subject: UMLS:C4684875

subject_name: Anti-PD-1 Monoclonal Antibody Sym021

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4684875

object_name: Embolism, Tumor


subject: UMLS:C4684875

object_name: Neoplasm Metastasis


subject: UMLS:C5447538

subject_name: Anti-CD73 Monoclonal Antibody Sym024

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447538

object_name: Adult Solid Neoplasm


subject: UMLS:C5447538

object_name: Solid Neoplasm


subject: UMLS:C5447538


subject: UMLS:C5447538


subject: UMLS:C5447538


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Oral Pain


subject: UNII:T42P99266K

object_name: Oral Pain, CTCAE 5.0


subject: UNII:T42P99266K

object_name: Primary malignant neoplasm


subject: UNII:T42P99266K

object_name: cancer


subject: UNII:T42P99266K

object_name: childhood malignant neoplasm


subject: UNII:T42P99266K

object_name: Malignant obstetric neoplasm


subject: UNII:T42P99266K

object_name: stomatitis


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: UMLS:C5666891

subject_name: ATI 450

object_name: rheumatoid arthritis


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:28887

object_name: Lymphoma, Intermediate-Grade


subject: CHEBI:28887

object_name: Lymphoma, Low-Grade


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:37659

subject_name: oleanolic acid

object_name: osteoarthritis


subject: CHEBI:138856

subject_name: Oxolinic acid


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: foot fracture


subject: PUBCHEM.COMPOUND:9971980

object_name: Acute Pain


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:32250


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: hepatoblastoma


subject: UMLS:C4086713

object_name: transitional cell neoplasm


subject: UMLS:C4086713

object_name: transitional cell carcinoma


subject: UMLS:C4086713


subject: UMLS:C4086713

object_name: liver cancer


subject: UMLS:C4086713

object_name: liver neoplasm


subject: UMLS:C4086713

object_name: Adult Liver Carcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Cooley's anemia


subject: CHEBI:28939

object_name: beta thalassemia


subject: UMLS:C4727173

subject_name: Aspacytarabine

object_name: Refractory acute myeloid leukemia


subject: UMLS:C4727173

object_name: adult acute myeloid leukemia


subject: UMLS:C4727173

object_name: Recurrence


subject: UMLS:C4727173

object_name: Miller-Dieker lissencephaly syndrome


subject: UMLS:C4727173

object_name: myoclonic dystonia 11


subject: PUBCHEM.COMPOUND:3222

object_name: sickle cell disease


subject: CHEBI:4784

subject_name: Enalapril


subject: UMLS:C1446848

subject_name: Silk antigen

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C1446848

object_name: non-Hodgkin lymphoma


subject: UMLS:C1446848

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C1446848

object_name: Childhood Non-Hodgkin Lymphoma


subject: DRUGBANK:DB10609

subject_name: Bombyx mori fiber


subject: DRUGBANK:DB10609


subject: DRUGBANK:DB10609


subject: DRUGBANK:DB10609


subject: UMLS:C0074529

subject_name: Silk


subject: UMLS:C0074529


subject: UMLS:C0074529


subject: UMLS:C0074529


subject: CHEBI:231679

subject_name: ipilimumab

object_name: endometrium adenocarcinoma


subject: CHEBI:231679

object_name: endometrial endometrioid adenocarcinoma


subject: CHEBI:231679

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:231679

object_name: endometrial mucinous adenocarcinoma


subject: CHEBI:231679

object_name: Endometrial Dedifferentiated Carcinoma


subject: CHEBI:231679

object_name: endometrial undifferentiated carcinoma


subject: CHEBI:231679

object_name: undifferentiated carcinoma of the corpus uteri


subject: CHEBI:231679

object_name: endometrial mixed adenocarcinoma


subject: UNII:3JL137394Y

object_name: type 2 diabetes mellitus


subject: UNII:3JL137394Y

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:95341

subject_name: Baricitinib

object_name: liver disorder


subject: CHEBI:95341

object_name: liver failure


subject: UMLS:C0019686

subject_name: HIV Antigens

object_name: HIV infection


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: allergic asthma


subject: UNII:7D0YB67S97

object_name: IgE-mediated allergic asthma


subject: UNII:7D0YB67S97

object_name: extrinsic asthma


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:37924

subject_name: Atazanavir

object_name: inherited lipid metabolism disorder


subject: CHEBI:37924

object_name: Dyslipidemia


subject: CHEBI:36791

subject_name: Escitalopram

object_name: bipolar I disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Advanced Pancreatic Carcinoma


subject: CHEBI:60775

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:60775

object_name: Locally Advanced Pancreatic Carcinoma


subject: CHEBI:60775

object_name: pancreatic neoplasm


subject: CHEBI:60775

object_name: malignant pancreatic neoplasm


subject: CHEBI:60775

object_name: stage IV pancreatic cancer


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEBI:32139

object_name: asymptomatic hyperuricemia


subject: CHEBI:32139

object_name: Hyperuricemia without signs of inflammatory arthritis and tophaceous disease


subject: CHEBI:32139

object_name: gout


subject: CHEBI:59527

object_name: Menorrhagia


subject: CHEBI:59527

object_name: Menorrhagia, CTCAE


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:91939


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: PUBCHEM.COMPOUND:129165016

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:9916099

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PUBCHEM.COMPOUND:9916099

object_name: Malignant Solid Neoplasm


subject: UMLS:C5238987

object_name: nasopharyngeal carcinoma


subject: UMLS:C5238987

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:464OXX39Y6

subject_name: Dinalbuphine sebacate

object_name: Obstructive sleep apnea hypopnea syndrome


subject: UNII:464OXX39Y6

object_name: Acute Pain


subject: CHEBI:231416

subject_name: Danicopan


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: epicondylitis


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: MESH:C539259

subject_name: EpiCeram


subject: MESH:C539259

object_name: dermatitis


subject: MESH:C539259

object_name: Eczema, CTCAE


subject: MESH:C539259

object_name: asthma


subject: MESH:C539259

object_name: food allergy


subject: UMLS:C4744528

subject_name: Zirconium panitumumab Zr-89

object_name: pancreatic neoplasm


subject: UMLS:C4744528

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4744528

object_name: malignant pancreatic neoplasm


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: heart failure


subject: CHEBI:31300

object_name: congestive heart failure


subject: CHEBI:31300

object_name: Rheumatic mitral stenosis


subject: CHEBI:31300

object_name: Mitral stenosis


subject: CHEBI:31300

object_name: Secondary pulmonary hypertension


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:51450


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Retinal neovascularization


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: hypoparathyroidism


subject: UMLS:C3540792

object_name: Hypoparathyroidism, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Alzheimer disease


subject: CHEBI:39867

subject_name: Valproic acid


subject: UNII:H5RNU52ZKK

subject_name: NELITOLIMOD

object_name: metastatic colorectal cancer


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Subacromial bursitis


subject: CHEBI:50858

object_name: frozen shoulder


subject: CHEBI:50858

object_name: Shoulder pain


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3540725


subject: UMLS:C3540725


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3539185


subject: UMLS:C3539185


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540726


subject: UMLS:C3540726


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C3540727


subject: UMLS:C3540727


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C5203463

subject_name: Sodium Nitrite Liquid Injection

object_name: sickle cell disease


subject: CHEBI:78870

subject_name: sodium nitrite


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377

object_name: Niemann-Pick disease


subject: CHEBI:15377

object_name: Childhood Brain Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: suppressor of tumorigenicity 3


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: GTOPDB:4985


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: CHEBI:91418

subject_name: Foretinib

object_name: cancer


subject: CHEBI:91418

object_name: neoplasm


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: anus cancer


subject: CHEBI:59495

object_name: anal carcinoma


subject: CHEBI:59495

object_name: precancerous condition


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:3696


subject: CHEBI:3696


subject: UNII:2N71QUE3NL

object_name: adult hepatocellular carcinoma


subject: UNII:2N71QUE3NL

object_name: liver cancer


subject: UNII:2N71QUE3NL

object_name: pediatric hepatocellular carcinoma


subject: UNII:2N71QUE3NL

object_name: liver carcinoma


subject: UNII:2N71QUE3NL

object_name: liver neoplasm


subject: UNII:2N71QUE3NL

object_name: Adult Liver Carcinoma


subject: UMLS:C3640817

subject_name: Ipafricept


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: UMLS:C3640817


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Malignant melanoma stage IV


subject: CHEBI:63637

subject_name: Vemurafenib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:63637

object_name: BRAF V600 Protein Variation


subject: UMLS:C4530095

subject_name: varicella zoster virus glycoprotein E, recombinant

object_name: EXCESS LMW-DNA


subject: CHEBI:60799

subject_name: Esketamine

object_name: Atypical behavior


subject: CHEBI:134724

subject_name: Ipragliflozin

object_name: hepatobiliary disorder


subject: CHEBI:134724

object_name: liver disorder


subject: UMLS:C4742129


subject: UMLS:C4742129


subject: UMLS:C3241978

subject_name: Human Papillomavirus 16 E7 Peptide

object_name: cervical cancer


subject: UMLS:C3241978

object_name: cervical carcinoma


subject: UMLS:C3827109

subject_name: JAK Inhibitor INCB047986

object_name: rheumatoid arthritis


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: lung cancer


subject: UNII:3A58010674

object_name: lung neoplasm


subject: UNII:3A58010674

object_name: lung carcinoma


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Plexosarcoma


subject: CHEBI:144046

subject_name: Diflomotecan

object_name: small cell lung carcinoma


subject: UMLS:C0965785


subject: UMLS:C4305781

object_name: Heartburn


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: Achilles tendon pain


subject: CHEBI:28787

object_name: Tendinopathy


subject: PUBCHEM.COMPOUND:27991

subject_name: dAVP

object_name: hemophilia A


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: UNII:5G1WE425BI

subject_name: Rilzabrutinib

object_name: chronic idiopathic urticaria


subject: UNII:NWN58M4F5T

subject_name: RILZABRUTINIB


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Non-Cancer Diagnosis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:74707

subject_name: Met-Met

object_name: bladder tumor


subject: CHEBI:74707

object_name: urinary bladder carcinoma


subject: CHEBI:74707

object_name: urinary bladder cancer


subject: CHEBI:74707

object_name: childhood bladder carcinoma


subject: CHEBI:53458


subject: CHEBI:53458


subject: CHEBI:53458


subject: CHEBI:53458


subject: UNII:9JD9B4S53T

object_name: Pre T-ALL


subject: UNII:9JD9B4S53T

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:9JD9B4S53T

object_name: myeloid leukemia


subject: UNII:9JD9B4S53T

object_name: Myelodysplasia


subject: CHEBI:49140

object_name: neuroendocrine neoplasm


subject: CHEBI:49140

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:49140

object_name: digestive system neuroendocrine neoplasm


subject: CHEBI:49140

object_name: neuroendocrine carcinoma


subject: CHEBI:49140

object_name: Metastatic neuroendocrine carcinoma


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: UNII:N3858377KC


subject: UNII:N3858377KC


subject: UNII:N3858377KC


subject: UNII:N3858377KC


subject: UMLS:C5691182

object_name: cystic fibrosis


subject: CHEBI:16962

subject_name: Cortisone

object_name: adrenocortical insufficiency


subject: CHEBI:16962

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:16962

object_name: Androgen excess


subject: UMLS:C1832015

object_name: adult acute myeloid leukemia


subject: UMLS:C1832015

object_name: childhood acute myeloid leukemia


subject: UMLS:C1832015

object_name: acute myeloid leukemia


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: primary peritoneal carcinoma


subject: UNII:TWF0ML1CK8

object_name: papillary serous cystadenocarcinoma


subject: UNII:TWF0ML1CK8

object_name: peritoneal carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: fallopian tube carcinoma


subject: UNII:5S371K6132

object_name: fallopian tube cancer


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: UNII:5S371K6132


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: familial pityriasis rubra pilaris


subject: UMLS:C1314412

object_name: pityriasis rubra pilaris


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: UNII:ELK3V90G6C


subject: UMLS:C5666901

subject_name: Pyruvate Kinase-R Activator AG-946

object_name: sickle cell disease


subject: UMLS:C3714169

object_name: Atopic rhinitis


subject: UMLS:C3714169

object_name: Hay fever


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Antibody-mediated rejection


subject: UNII:R30772KCU0

object_name: Allosensitization


subject: UMLS:C2983777


subject: UMLS:C2983777


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: portal vein thrombosis


subject: PUBCHEM.COMPOUND:46783403

object_name: Portal Vein Thrombosis, CTCAE


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Primary Graft Dysfunction


subject: CHEBI:38290

object_name: Complication of transplanted lung


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: prolymphocytic leukemia


subject: PUBCHEM.COMPOUND:73005958

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:73005958

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:73005958

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:73005958

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: radiodermatitis


subject: CHEBI:231951

object_name: Overweight


subject: UMLS:C1099192

object_name: female infertility


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: placental abruption


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Primary malignant neoplasm


subject: UNII:7D0YB67S97

object_name: cancer


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C3537103

subject_name: Nucleoside Reverse Transcriptase Inhibitor

object_name: malaria


subject: CHEBI:73501

subject_name: Glu-Phe-Val


subject: DRUGBANK:DB06017

object_name: Crohn disease


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Binge eating behavior


subject: CHEBI:66910

subject_name: Axitinib

object_name: renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:DOB7Y3RSX0

subject_name: HPPH

object_name: Recurrent Thyroid Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Recurrent Salivary Gland Cancer


subject: UNII:DOB7Y3RSX0

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:DOB7Y3RSX0

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:DOB7Y3RSX0

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:DOB7Y3RSX0

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0


subject: UNII:DOB7Y3RSX0

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:DOB7Y3RSX0

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:DOB7Y3RSX0

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UNII:DOB7Y3RSX0

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UNII:DOB7Y3RSX0

object_name: Salivary gland cancer stage I


subject: UNII:DOB7Y3RSX0

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: stage I squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage II squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage I midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage I inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage II midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: stage II inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:DOB7Y3RSX0

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: Salivary gland cancer stage II


subject: UNII:DOB7Y3RSX0

object_name: Stage I Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: Hypopharyngeal squamous cell carcinoma stage I


subject: UNII:DOB7Y3RSX0

object_name: Laryngeal squamous cell carcinoma stage I


subject: UNII:DOB7Y3RSX0

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: Stage I Thyroid Gland Follicular Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: Stage II Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: Hypopharyngeal squamous cell carcinoma stage II


subject: UNII:DOB7Y3RSX0

object_name: Laryngeal squamous cell carcinoma stage II


subject: UNII:DOB7Y3RSX0

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: Stage I Lip Basal Cell Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: UNII:DOB7Y3RSX0

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: UNII:DOB7Y3RSX0

object_name: Stage II Thyroid Gland Follicular Carcinoma AJCC v7


subject: UNII:DOB7Y3RSX0

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: UNII:DOB7Y3RSX0

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: UNII:DOB7Y3RSX0

object_name: Stage II Lip Basal Cell Carcinoma


subject: UNII:DOB7Y3RSX0

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: UNII:DOB7Y3RSX0

object_name: Oropharyngeal lymphoepithelioma stage I


subject: UNII:DOB7Y3RSX0

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: UNII:DOB7Y3RSX0

object_name: Laryngeal verrucous carcinoma stage I


subject: UNII:DOB7Y3RSX0

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:DOB7Y3RSX0

object_name: Oropharyngeal lymphoepithelioma stage II


subject: UNII:DOB7Y3RSX0

object_name: Laryngeal verrucous carcinoma stage II


subject: UNII:DOB7Y3RSX0

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C5237346

subject_name: STING Agonist IMSA101

object_name: Oligometastatic malignant neoplasm


subject: CHEBI:45783

subject_name: Imatinib

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Childhood Breast Carcinoma


subject: CHEBI:7915

object_name: breast carcinoma


subject: CHEBI:7915

object_name: breast cancer


subject: CHEBI:7915

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:7915

object_name: neoplasm


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: invasive breast carcinoma


subject: MESH:C000629782

object_name: breast ductal adenocarcinoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UMLS:C3541396

subject_name: Zinc Supplements

object_name: Neonatal infection


subject: CHEBI:63632

subject_name: Topotecan

object_name: Recurrent Brain Neoplasm


subject: PUBCHEM.COMPOUND:170128935

subject_name: Olomorasib

object_name: non-small cell lung carcinoma


subject: UNII:C2VJ83PSN7

subject_name: OLOMORASIB


subject: UMLS:C5417813

subject_name: Fc-engineered Anti-CD40 Agonist Antibody 2141-V11

object_name: malignant glioma


subject: UNII:W89H91R7VX

subject_name: Arbaclofen Placarbil

object_name: alcohol abuse


subject: UNII:W89H91R7VX

object_name: alcohol dependence


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Sedation


subject: CHEBI:9130

object_name: Sedated


subject: CHEBI:125427

object_name: IgA Nephropathy


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: UMLS:C1176021

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:9834332

subject_name: Brivaracetam

object_name: Unverricht-Lundborg syndrome


subject: UMLS:C5239413

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5239413

object_name: non-Hodgkin lymphoma


subject: CHEBI:10033

subject_name: Warfarin

object_name: Major bleed


subject: UMLS:C0445115

subject_name: Normal saline

object_name: epicondylitis


subject: RXCUI:659877

subject_name: Gardasil

object_name: Genital Human Papillomavirus Infection


subject: CHEBI:140407

subject_name: Ceftobiprole

object_name: ventilator-associated pneumonia


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Infection


subject: UMLS:C0003442

object_name: infectious disease


subject: UMLS:C0003442

object_name: Adverse Event Associated with Infection


subject: UMLS:C0003442

object_name: small intestine cancer


subject: UMLS:C0003442

object_name: small intestine carcinoma


subject: UMLS:C0003442

object_name: precancerous condition


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide

object_name: graft versus host disease


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911

object_name: Myelofibrosis due to another disorder


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEMBL.COMPOUND:CHEMBL3833331

object_name: Multiple sclerosis relapse


subject: UMLS:C5666933

subject_name: PM 14

object_name: Localized Soft Tissue Sarcoma


subject: UMLS:C5666933

object_name: Advanced Soft Tissue Sarcoma


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Muscle Pain, CTCAE


subject: CHEBI:6339

object_name: Myalgia


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Premature birth


subject: CHEBI:63610

object_name: premature birth (history)


subject: CHEBI:17579

subject_name: Beta carotene

object_name: cancer


subject: CHEBI:17579

object_name: Mental deterioration


subject: CHEBI:17579

object_name: Cognitive impairment


subject: CHEBI:17579

object_name: eye disorder


subject: CHEBI:17579

object_name: cardiovascular disorder


subject: CHEBI:17579

object_name: prostate carcinoma


subject: CHEBI:17579

object_name: prostate cancer


subject: CHEBI:17579

object_name: colorectal cancer


subject: CHEBI:17579

object_name: colorectal carcinoma


subject: CHEBI:17579

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0301532

subject_name: Multivitamin preparation


subject: UMLS:C0301532

object_name: neoplasm


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: UMLS:C0301532


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: UMLS:C0062527

subject_name: Engerix-B

object_name: Human Papilloma Virus, Female


subject: UMLS:C0062527

object_name: Human Papilloma Virus, Male


subject: UMLS:C0062527

object_name: cervical cancer


subject: UMLS:C0062527

object_name: cervical carcinoma


subject: UMLS:C0062527

object_name: Mental health issue


subject: UMLS:C0062527

object_name: liver cancer


subject: UMLS:C0062527

object_name: liver neoplasm


subject: UMLS:C0062527

object_name: Adult Liver Carcinoma


subject: UMLS:C0062527

object_name: liver carcinoma


subject: UMLS:C0062527

object_name: mixed anxiety and depressive disorder


subject: UMLS:C0062527

object_name: Gall stones (& [calculus - gall bladder])


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: hepatobiliary disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: liver disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Decreased liver function


subject: CHEBI:64816

object_name: childhood malignant neoplasm


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: childhood onset asthma


subject: UNII:2P471X1Z11

object_name: allergy; anaphylactic shock, food


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Neuropathic pain


subject: CHEBI:6128

subject_name: Ketoprofen


subject: CHEBI:62088

subject_name: Metamizole


subject: CHEBI:58097

object_name: neuralgia


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: abscess


subject: UMLS:C0041044


subject: CHEBI:71940

subject_name: Tadalafil

object_name: glioblastoma


subject: CHEBI:71940

object_name: anaplastic astrocytoma


subject: UMLS:C4733610

object_name: Hodgkin Disease


subject: UMLS:C4733610

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C4733610

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C0770261

subject_name: Dextrose 20% and Water

object_name: type 1 diabetes mellitus


subject: UMLS:C0770261

object_name: insulin sensitivity/resistance


subject: CHEBI:80270


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C3883362

subject_name: Programmed Death Receptor-1 Blocking Antibody

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Coronavinae infectious disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: male breast carcinoma


subject: CHEBI:25681

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:25681

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:25681

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:25681

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:25681

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:25681

object_name: stage IA breast cancer


subject: CHEBI:25681

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:25681

object_name: lobular breast carcinoma in situ


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C3536908

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: male breast carcinoma


subject: UMLS:C3536908

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C3536908

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3536908

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3536908

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C3536908

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Stage IA Breast Cancer AJCC v7


subject: UMLS:C3536908

object_name: stage IA breast cancer


subject: UMLS:C3536908

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C3536908

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C3536908

object_name: lobular breast carcinoma in situ


subject: CHEBI:8382

subject_name: Prednisone

object_name: post-traumatic stress disorder


subject: CHEBI:77733

subject_name: Verapamil

object_name: cluster headache syndrome


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: chronic leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: MESH:C522236

subject_name: technetium 99m ethylenedicysteine deoxyglucose

object_name: Neck Carcinoma


subject: MESH:C522236

object_name: head and neck neoplasm


subject: MESH:C522236

object_name: head and neck cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Niemann-Pick disease type C


subject: CHEBI:15379

subject_name: Oxygen

object_name: prosthesis-related infectious disease


subject: CHEBI:15379

object_name: non-arteritic anterior ischemic optic neuropathy


subject: CHEBI:15379

object_name: Greater trochanteric pain syndrome


subject: CHEBI:15379

object_name: Ligament injury


subject: CHEBI:15379

object_name: Invasive fungal infection


subject: CHEBI:15379

object_name: central retinal vein occlusion


subject: CHEBI:15379

object_name: osteonecrosis


subject: CHEBI:15379

object_name: avascular necrosis


subject: CHEBI:15379

object_name: ulcerative colitis


subject: CHEBI:15379

object_name: inflammatory bowel disease 1


subject: CHEBI:15379

object_name: Clostridium difficile colitis


subject: CHEBI:15379

object_name: branch retinal artery occlusion


subject: CHEBI:15379

object_name: multiple sclerosis


subject: CHEBI:15379

object_name: inclusion body myositis


subject: CHEBI:15379

object_name: epidermolysis bullosa


subject: CHEBI:15379

object_name: malignant otitis externa


subject: CHEBI:15379

object_name: Intramural intestinal gas


subject: CHEBI:15379

object_name: Femoral head necrosis


subject: CHEBI:15379

object_name: Chronic anal fissure


subject: CHEBI:15379

object_name: pyoderma gangrenosum


subject: CHEBI:15379

object_name: Rectovaginal fistula


subject: CHEBI:15379

object_name: Anastomosis, leaking


subject: CHEBI:15379

object_name: graft versus host disease


subject: CHEBI:15379

object_name: Vasculitic ulcer


subject: CHEBI:15379

object_name: chronic cystitis


subject: CHEBI:15379

object_name: Raynaud disease


subject: CHEBI:15379

object_name: Cartilage injury


subject: CHEBI:15379

object_name: decubitus ulcer


subject: CHEBI:15379

object_name: hypospadias


subject: CHEBI:15379

object_name: Penile hypospadias


subject: CHEBI:15379

object_name: Arterial ulcer


subject: CHEBI:15379

object_name: bowel ischemic


subject: CHEBI:15379

object_name: Acute COVID-19


subject: CHEBI:15379

object_name: calciphylaxis


subject: CHEBI:15379

object_name: Crohn disease


subject: CHEBI:15379

object_name: Osteonecrosis, CTCAE


subject: CHEBI:15379

object_name: Axonotmesis


subject: CHEBI:15379

object_name: Head Injury


subject: CHEBI:15379

object_name: Frostbite


subject: CHEBI:15379

object_name: pouchitis


subject: CHEBI:15379

object_name: pterygium


subject: CHEBI:15379

object_name: conjunctival pterygium


subject: CHEBI:15379

object_name: Tinnitus


subject: CHEBI:15379

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:15379

object_name: Tinnitus, CTCAE 3.0


subject: UMLS:C0169964

subject_name: somatropin

object_name: brain injury


subject: UMLS:C1176324

object_name: myeloproliferative neoplasm


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin

object_name: Ovulation disorder


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: bile duct carcinoma


subject: UNII:8M7YSN2KII

object_name: bile duct cancer


subject: UNII:8M7YSN2KII

object_name: cholangiocarcinoma


subject: UNII:8M7YSN2KII

object_name: GASTRIC CANCER ADENOCARCINOMA METASTATIC


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: CHEBI:135117

subject_name: ftivazide

object_name: hepatitis A


subject: CHEBI:135117

object_name: hepatitis


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: CHEBI:45285


subject: UMLS:C1134588

object_name: prostate carcinoma


subject: UMLS:C1134588

object_name: prostate cancer


subject: UMLS:C1876840

subject_name: Biafine Cream

object_name: Neck Carcinoma


subject: UMLS:C1876840

object_name: head and neck neoplasm


subject: UMLS:C1876840

object_name: head and neck cancer


subject: UMLS:C1876840

object_name: Skin Reaction Secondary to Radiation Therapy


subject: PUBCHEM.COMPOUND:16119086

object_name: Atopic rhinitis


subject: PUBCHEM.COMPOUND:16119086

object_name: Allergic Rhinitis, CTCAE


subject: UNII:G3QE979K1X


subject: UNII:G3QE979K1X


subject: CHEBI:31781

subject_name: Lopinavir

object_name: Kaposi Sarcoma


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:22972

subject_name: butyryl group

object_name: tuberculosis


subject: CHEBI:22927

subject_name: bromine atom


subject: CHEBI:22925

subject_name: bromide salt


subject: UNII:VG5Y3A9DFS

subject_name: FELMETATUG VEDOTIN

object_name: triple-negative breast carcinoma


subject: UNII:VG5Y3A9DFS

object_name: non-small cell lung carcinoma


subject: UNII:VG5Y3A9DFS

object_name: fallopian tube neoplasm


subject: UNII:VG5Y3A9DFS

object_name: adrenal cortex carcinoma


subject: UNII:VG5Y3A9DFS

object_name: adenoid cystic carcinoma


subject: UNII:VG5Y3A9DFS

object_name: gallbladder carcinoma


subject: UNII:VG5Y3A9DFS

object_name: endometrium neoplasm


subject: UNII:VG5Y3A9DFS

object_name: peritoneal neoplasm


subject: UNII:VG5Y3A9DFS

object_name: cholangiocarcinoma


subject: UNII:VG5Y3A9DFS

object_name: ovarian cancer


subject: UNII:VG5Y3A9DFS

object_name: ovarian neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:32914

subject_name: Cetylpyridinium

object_name: periodontal disorder


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Microsatellite Stable Rectal Carcinoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Postoperative Hemorrhage


subject: PUBCHEM.COMPOUND:53477758

object_name: Intraoperative Hemorrhage


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:31563

subject_name: Etamsylate


subject: CHEBI:31563


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Reduced left ventricular ejection fraction


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Recurrent Transformed Chronic Lymphocytic Leukemia


subject: CHEBI:91397

object_name: Refractory Transformed Chronic Lymphocytic Leukemia


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: Richter syndrome


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5814270

object_name: allergic asthma


subject: CHEBI:60775

subject_name: Verteporfin

object_name: Chronic central serous chorioretinopathy


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: hemophagocytic syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:135928

subject_name: Doripenem

object_name: pyelonephritis


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:52717

object_name: Nasopharyngeal cancer metastatic


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:HX02FQ94ZX

object_name: primary progressive multiple sclerosis


subject: UNII:HX02FQ94ZX

object_name: Multiple sclerosis relapse


subject: UNII:HX02FQ94ZX

object_name: secondary progressive multiple sclerosis


subject: UNII:HX02FQ94ZX

object_name: multiple sclerosis


subject: UMLS:C5691184


subject: UMLS:C5691184


subject: UMLS:C5691184


subject: UMLS:C5691184


subject: CHEBI:138650

object_name: Solid Neoplasm


subject: CHEBI:138650

object_name: glioblastoma


subject: CHEBI:138650

object_name: Childhood Glioblastoma


subject: CHEBI:138650

object_name: adult glioblastoma


subject: UMLS:C3827145


subject: UMLS:C3827145


subject: UMLS:C3827145


subject: UMLS:C3827145


subject: CHEBI:30772

subject_name: Butyric Acid

object_name: type 1 diabetes mellitus 1


subject: CHEBI:30772

object_name: type 1 diabetes mellitus


subject: CHEBI:132889

subject_name: graphene oxide

object_name: acute myeloid leukemia


subject: CHEBI:58097

object_name: Physical addiction


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773

object_name: Opioid withdrawal


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: metastatic malignant neoplasm in the brain


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: UNII:GQE1BJE2NI

subject_name: intetumumab

object_name: prostate cancer


subject: UNII:GQE1BJE2NI

object_name: prostate neoplasm


subject: UMLS:C1881068


subject: UMLS:C1881068


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919

object_name: bronchiolitis obliterans syndrome


subject: CHEBI:66919

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:66919

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: Breast cancer recurrent


subject: CHEBI:3764

subject_name: Clotrimazole

object_name: vulvovaginal candidiasis


subject: UMLS:C5854330

subject_name: AAA 517


subject: UMLS:C5854330


subject: UMLS:C5962170

subject_name: Androgen Receptor Pathway Inhibitor


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: vitamin D deficiency


subject: UniProtKB:P19726

object_name: primary hyperparathyroidism


subject: CHEBI:2659

subject_name: Aminophylline

object_name: no feeling or sensation of skin


subject: CHEBI:2659

object_name: Sensory Loss


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: alopecia areata


subject: PUBCHEM.COMPOUND:71622431

object_name: alopecia


subject: UMLS:C5565994


subject: UMLS:C5565994


subject: CHEBI:32599

object_name: Placenta Previa


subject: PUBCHEM.COMPOUND:129627881

subject_name: Noac

object_name: intracerebral hemorrhage


subject: CHEBI:231132

subject_name: N(4)-Oleylcytosine arabinoside


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant


subject: UMLS:C0687700

subject_name: CCNU

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C0687700

object_name: Recurrent Glioblastoma


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:681569

subject_name: Clofarabine

object_name: Langerhans cell histiocytosis specific to childhood


subject: CHEBI:681569

object_name: Langerhans cell histiocytosis specific to adulthood


subject: CHEBI:18132

subject_name: phosphocholine

object_name: High risk of


subject: CHEBI:18132

object_name: High risk


subject: CHEBI:18132

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: CHEBI:18132

object_name: High Risk Acute Leukemia


subject: CHEBI:18132

object_name: International Prognostic Index High Risk Group


subject: UniProtKB:Q62857

subject_name: DDIT3_RAT DNA damage-inducible transcript 3 protein (sprot)


subject: UniProtKB:Q62857


subject: UniProtKB:Q62857


subject: UniProtKB:Q62857


subject: UniProtKB:Q62857


subject: PR:000006347

subject_name: DNA damage-inducible transcript 3 protein


subject: PR:000006347


subject: PR:000006347


subject: PR:000006347


subject: PR:000006347


subject: UMLS:C2718754

subject_name: Ilaris

object_name: temporal arteritis


subject: UMLS:C2718754

object_name: polymyalgia rheumatica


subject: UMLS:C2718754

object_name: inflammatory disease


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: central retinal vein occlusion


subject: CHEBI:7563

object_name: Branch retinal vein occlusion


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: MESH:D009539


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: UMLS:C3714626


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: UMLS:C3536880


subject: UNII:UVJ7NL8S2P

subject_name: Imlifidase

object_name: thrombotic thrombocytopenic purpura


subject: UNII:UVJ7NL8S2P

object_name: acquired thrombotic thrombocytopenic purpura


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: UNII:7NL2E3F6K3

subject_name: Emicizumab

object_name: Immune Tolerance


subject: UMLS:C0700346

subject_name: Koate-DVI


subject: MESH:C018655

subject_name: Rowachol

object_name: postcholecystectomy syndrome


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Prehypertension


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Sickle cell anemia in children


subject: CHEBI:167309

subject_name: Methadone

object_name: precancerous condition


subject: CHEBI:167309


subject: CHEBI:167309

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:167309

object_name: myeloproliferative neoplasm


subject: CHEBI:167309

object_name: lymphoproliferative syndrome


subject: CHEBI:167309

object_name: Myelodysplasia


subject: CHEBI:167309

object_name: adult lymphoma


subject: CHEBI:167309

object_name: lymphoma


subject: CHEBI:167309

object_name: pediatric lymphoma


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731

object_name: leukemia


subject: CHEBI:50731

object_name: childhood leukemia


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: UNII:E628ZH6U2C

object_name: plasma cell myeloma


subject: UNII:QY50S617NM


subject: UMLS:C2348995


subject: CHEBI:145499

subject_name: Donepezil

object_name: Acute Stroke


subject: CHEBI:145499

object_name: Acute Stroke Related to COVID-19


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Distal Radius Fractures


subject: UMLS:C4086546

object_name: wrist fracture


subject: CHEBI:6456

subject_name: Lidocaine

object_name: neoplasm


subject: GTOPDB:13305

subject_name: linvoseltamab

object_name: Plasma cell myeloma refractory


subject: GTOPDB:13305

object_name: Triple-Class Refractory Multiple Myeloma


subject: GTOPDB:13305

object_name: Plasma cell myeloma recurrent


subject: UNII:M3CPC50MZS

subject_name: LINVOSELTAMAB


subject: UNII:M3CPC50MZS


subject: UNII:M3CPC50MZS


subject: UMLS:C4764258

subject_name: Linvoseltamab


subject: UMLS:C4764258


subject: UMLS:C4764258


subject: PR:000008603

subject_name: histone H4

object_name: tuberculosis


subject: UniProtKB:P84040

subject_name: H4_DROME Histone H4 (sprot)


subject: RXCUI:236782

subject_name: Saccharomyces boulardii Oral Capsule

object_name: Helicobacter pylori infection


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: self-limited epilepsy with centrotemporal spikes


subject: UNII:KT0ZQ64X1A

object_name: Blast Phase


subject: UNII:KT0ZQ64X1A

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:KT0ZQ64X1A

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:KT0ZQ64X1A

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:KT0ZQ64X1A

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:KT0ZQ64X1A

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:KT0ZQ64X1A

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:KT0ZQ64X1A

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:KT0ZQ64X1A

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:KT0ZQ64X1A

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: UNII:KT0ZQ64X1A

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:KT0ZQ64X1A

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:KT0ZQ64X1A

object_name: recurrent adult acute myeloid leukemia


subject: UNII:KT0ZQ64X1A

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Malignant neoplasm of female breast


subject: CHEBI:34954

subject_name: (S)-ropivacaine hydrochloride hydrate


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:78236

subject_name: N-acetyl-L-cysteinate

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:78236

object_name: acute myeloid leukemia


subject: UNII:2SPH1IMO2V

subject_name: N-Acetyl-D-cysteine


subject: UNII:2SPH1IMO2V


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: diabetes mellitus, noninsulin-dependent, 2


subject: CHEBI:37941

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: coronary artery disorder


subject: CHEBI:6375

object_name: coronary atherosclerosis


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: carcinoid tumor


subject: CHEBI:90001

object_name: medulloblastoma


subject: CHEBI:90001

object_name: childhood medulloblastoma


subject: CHEBI:90001

object_name: adult medulloblastoma


subject: CHEBI:90001

object_name: Childhood Neuroblastoma


subject: CHEBI:90001

object_name: neuroblastoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:77572

subject_name: Tranilast

object_name: mucinoses


subject: CHEMBL.COMPOUND:CHEMBL1743042

subject_name: MOTAVIZUMAB

object_name: Wheezing


subject: CHEMBL.COMPOUND:CHEMBL1743042

object_name: Wheezing, CTCAE


subject: UMLS:C1667763


subject: UMLS:C1667763


subject: UMLS:C4723608

subject_name: Betamethasone Dipropionate Ointment

object_name: Chronic small plaque psoriasis


subject: PUBCHEM.COMPOUND:2791

subject_name: Clobetasol propionate


subject: GTOPDB:1160

subject_name: hCG

object_name: azoospermia


subject: GTOPDB:1160

object_name: Azoospermia, CTCAE


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: CHEBI:81570


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: CHEBI:16831

subject_name: Meglutol


subject: CHEBI:16831


subject: UMLS:C0178700

subject_name: hydroxymethylglutarate


subject: UMLS:C0178700


subject: UMLS:C0025326

subject_name: Menotropins


subject: UMLS:C0025326


subject: UMLS:C3179325

subject_name: PRO 140

object_name: graft versus host disease


subject: CHEBI:62088

subject_name: Metamizole

object_name: pain agnosia


subject: CHEBI:62088

object_name: Pain insensitivity


subject: PUBCHEM.COMPOUND:11556075

subject_name: Contrave

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:11556075

object_name: obesity


subject: PUBCHEM.COMPOUND:11556075

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:11556075

object_name: Weight loss


subject: PUBCHEM.COMPOUND:11556075

object_name: Weight Loss, CTCAE


subject: RXCUI:1551466

subject_name: bupropion / naltrexone Extended Release Oral Tablet


subject: RXCUI:1551466


subject: RXCUI:1551466


subject: RXCUI:1551466


subject: RXCUI:1551466


subject: UMLS:C1328728

object_name: renal carcinoma


subject: UMLS:C1328728

object_name: kidney neoplasm


subject: UMLS:C1328728

object_name: kidney cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: untreated metastatic squamous neck cancer with occult primary


subject: UNII:2S9ZZM9Q9V

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:2S9ZZM9Q9V

object_name: Oropharyngeal lymphoepithelioma stage III


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IV Renal Cell Cancer


subject: UNII:PQX0D8J21J

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Pancreatic carcinoma stage III


subject: UNII:PQX0D8J21J

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: Stage III Lip Basal Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UNII:PQX0D8J21J

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UNII:PQX0D8J21J

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:PQX0D8J21J


subject: UNII:PQX0D8J21J

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:114785

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:114785


subject: CHEBI:114785

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage III Colon Cancer


subject: CHEBI:114785

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785

object_name: Salivary gland cancer stage III


subject: CHEBI:114785

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:114785


subject: MESH:D002214

subject_name: Capsules

object_name: cardiovascular disorder


subject: GTOPDB:4934

subject_name: G-CSF

object_name: relapsing-remitting multiple sclerosis


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: non-small cell lung carcinoma


subject: CHEBI:36704

subject_name: Imiquimod


subject: UNII:2S9ZZM9Q9V

object_name: leukemia


subject: UNII:2S9ZZM9Q9V

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: periodontal disorder


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:16261

subject_name: chitosan


subject: CHEBI:4975

subject_name: Famotidine

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: PUBCHEM.COMPOUND:71226663


subject: PUBCHEM.COMPOUND:129316491

object_name: Wolfram syndrome


subject: UMLS:C5774003


subject: CHEBI:143528

subject_name: DL-Arabinose

object_name: irritable bowel syndrome


subject: UNII:89NA02M4RX

subject_name: PECTIN


subject: CHEBI:17309

subject_name: pectin


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: melanoma


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:421707

subject_name: Abacavir

object_name: EXCESS LMW-DNA


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:60799

subject_name: Esketamine

object_name: Mechanical ventilation finding


subject: MESH:C030259

subject_name: Broncho-Vaxom

object_name: Too early


subject: MESH:C030259

object_name: Premature birth


subject: MESH:C030259

object_name: Recurrent lower respiratory tract infections


subject: DRUGBANK:DB16533


subject: DRUGBANK:DB16533


subject: DRUGBANK:DB16533


subject: UMLS:C0445115

subject_name: Normal saline

object_name: sinusitis


subject: UMLS:C0445115

object_name: Sinusitis, CTCAE


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Neuropathic spinal arthropathy


subject: PUBCHEM.COMPOUND:3086682

subject_name: nepadutant

object_name: Infantile Colic


subject: UMLS:C0664922

subject_name: Nepadutant


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated

object_name: meningococcal infection


subject: UMLS:C5240006

subject_name: Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)


subject: UMLS:C3644171

subject_name: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

object_name: meningococcal meningitis


subject: UMLS:C3644171


subject: UMLS:C3526553

subject_name: diphtheria, tetanus toxoids and acellular pertussis vaccine


subject: UMLS:C3526553


subject: CHEBI:75551

object_name: traumatic encephalopathy


subject: CHEBI:231666

object_name: Mild asthma


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: prolymphocytic leukemia


subject: CHEBI:47344

subject_name: Alvocidib


subject: UNII:KX89J0DFZ8

subject_name: IMSIDOLIMAB

object_name: Acne inversa


subject: UMLS:C0249056


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Parkinson disease


subject: UMLS:C2713523

object_name: infertility


subject: UMLS:C0242708

subject_name: Antirheumatic Drugs, Disease-Modifying


subject: UMLS:C0242708

object_name: Rheumatism


subject: CHEBI:231601

subject_name: trastuzumab

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:2639

subject_name: Amiloride

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:T0N62K2M2Y

object_name: EXCESS LMW-DNA


subject: CHEBI:177298

object_name: esophageal adenocarcinoma


subject: CHEBI:177298

object_name: lung adenocarcinoma


subject: CHEBI:177298

object_name: cervical adenocarcinoma


subject: CHEBI:177298

object_name: adenocarcinoma


subject: CHEBI:177298

object_name: bile duct adenocarcinoma